Article: article from journal or magazin.
Case report (case report): feedback on an observation with a short commentary.
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
International clinical psychopharmacology
Publication types: Case Reports ; Journal Article - Publication Status: ppublish
Plasma levels of clozapine and olanzapine are lower in smokers than in nonsmokers, which is mainly due to induction of cytochrome P4501A2 (CYP1A2) by some smoke constituents. Smoking cessation in patients treated with antipsychotic drugs that are CYP1A2 substrates may result in increased plasma levels of the drug and, consequently, in adverse drug effects. Two cases of patients who smoked tobacco and cannabis are reported. The first patient, who was receiving clozapine treatment, developed confusion after tobacco and cannabis smoking cessation, which was related to increased clozapine plasma levels. The second patient, who was receiving olanzapine treatment, showed important extrapyramidal motor symptoms after reducing his tobacco consumption. The clinical implication of these observations is that smoking patients treated with CYP1A2 substrate antipsychotics should regularly be monitored with regard to their smoking consumption in order to adjust doses in cases of a reduction or increase in smoking.
Adult, Antipsychotic Agents, Basal Ganglia Diseases, Benzodiazepines, Clozapine, Confusion, Cytochrome P-450 CYP1A2, Humans, Male, Marijuana Smoking, Pirenzepine, Smoking, Smoking Cessation
Web of science
Last modification date